Biotech News
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026
investors.angiodynamics.com2026-05-06 15:00 EST
LATHAM, N.Y. --(BUSINESS WIRE)--Dec. 23, 2025-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today